© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
March 13, 2017
Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.
Like a Vessel
Childhood Cancer Survivor Becomes Oncology Nurse and Hero
A Huge Heart for Patients With Lung Cancer
Imperfection After Breast Cancer